Another sad day for the Biotech sector. Falling over at Ph3 trials after years of promising progress and lost loyal investors money. Who would invest in Biotechs now with so many failures in the sector. Im just pleased Lopez isn't around to rub it in.
ph 3 trial fails primary endpoint, page-13
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
